Inflammation and ER stress downregulate BDH2 expression and dysregulate intracellular iron in macrophages

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Zughaier, Susu M ^a   Stauffer, Brandon B ^a   McCarty, Nael A ^a  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUTYRATE DEHYDROGENASE 2; FERROPORTIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEME OXYGENASE 1; HEPCIDIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; IRON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OXIDOREDUCTASE; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BDH2 PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; HYDROXYBUTYRATE DEHYDROGENASE; LCN2 PROTEIN, HUMAN; LIPOCALIN; LIPOPOLYSACCHARIDE; ONCOPROTEIN; SIDEROPHORE;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; IRON STORAGE; IRON TRANSPORT; MACROPHAGE; PROTEIN EXPRESSION; UPREGULATION; CELL LINE; ENDOPLASMIC RETICULUM; GENETICS; HOMEOSTASIS; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ACUTE-PHASE PROTEINS; CELL LINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; HEME OXYGENASE-1; HEPCIDINS; HOMEOSTASIS; HUMANS; HYDROXYBUTYRATE DEHYDROGENASE; INFLAMMATION; INTRACELLULAR SPACE; IRON; LIPOCALINS; LIPOPOLYSACCHARIDES; MACROPHAGES; PROTO-ONCOGENE PROTEINS; SIDEROPHORES; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 84918501318     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/140728     Document Type: Article

References (80)

1. J. Wang and K. Pantopoulos, "Regulation of cellular iron metabolism," Biochemical Journal, vol. 434, no. 3, pp. 365-381, 2011.
2. T. Ganz and E. Nemeth, "Hepcidin and disorders of iron metabolism," Annual Review of Medicine, vol. 62, pp. 347-360, 2011.
3. P. Lipinski, R. R. Starzynski, A. Stys, and M. Stracilo, "Iron homeostasis, a defense mechanism in oxidative stress," Postepy Biochemii, vol. 56, pp. 305-316, 2010.
4. X. Pan, B. Tamilselvam, E. J. Hansen, and S. Daefler, "Modulation of iron homeostasis in macrophages by bacterial intracellular pathogens," BMC Microbiology, vol. 10, article 64, 2010.
5. S. Recalcati, M. Locati, A. Marini et al., "Differential regulation of iron homeostasis during human macrophage polarized activation," European Journal of Immunology, vol. 40, no. 3, pp. 824-835, 2010.
6. T. Ganz, "The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease," The Israel Medical Association Journal: IMAJ, vol. 4, no. 11, pp. 1043-1045, 2002.
7. E. Nemeth, M. S. Tuttle, J. Powelson et al., "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization," Science, vol. 306, no. 5704, pp. 2090-2093, 2004.
8. E. Nemeth, S. Rivera, V. Gabayan et al., "IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin," The Journal of Clinical Investigation, vol. 113, no. 9, pp. 1271-1276, 2004.
9. E. Nemeth, E. V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz, "Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein," Blood, vol. 101, no. 7, pp. 2461-2463, 2003.
10. M. Theurl, I. Theurl, K. Hochegger et al., "Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression," Journal of Molecular Medicine, vol. 86, no. 7, pp. 825-835, 2008.
11. I. Theurl, M. Theurl, M. Seifert et al., "Autocrine formation of hepcidin induces iron retention in human monocytes," Blood, vol. 111, no. 4, pp. 2392-2399, 2008.
12. L. R. Devireddy, D. O. Hart, D. H. Goetz, and M. R. Green, "A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production," Cell, vol. 141, no. 6, pp. 1006-1017, 2010.
13. K. Guo, P. Lukacik, E. Papagrigoriou et al., "Characterization of human DHRS6, an orphan short chain dehydrogenase/ reductase enzyme: a novel, cytosolic type 2 R-β-hydroxybutyrate dehydrogenase," The Journal of Biological Chemistry, vol. 281, no. 15, pp. 10291-10297, 2006.
14. Z. Liu, R. Lanford, S. Mueller et al., "Siderophore-mediated iron trafficking in humans is regulated by iron," Journal of Molecular Medicine, vol. 90, no. 10, pp. 1209-1221, 2012.
15. S. M. Zughaier, J. L. Kandler, and W. M. Shafer, "Neisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages," PLoS ONE, vol. 9, no. 1, Article ID e87688, 2014.
16. Z. Liu, S. Reba, W.-D. Chen et al., "Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection," Journal of Experimental Medicine, vol. 211, no. 6, pp. 1197-1213, 2014.
17. Z. Liu, A. Ciocea, and L. Devireddy, "Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice," Molecular and Cellular Biology, vol. 34, no. 13, pp. 2533-2546, 2014.
18. Z. Liu, K. K. Velpula, and L. Devireddy, "3-Hydroxybutyrate dehydrogenase-2 and ferritin-H synergistically regulate intracellular iron," The FEBS Journal, vol. 281, no. 10, pp. 2410-2421, 2014.
19. A. Agarwal and S. Bolisetty, "Adaptive responses to tissue injury: role of heme oxygenase-1," Transactions of the American Clinical and Climatological Association, vol. 124, pp. 111-122, 2013.
20. T. D. Hull, S. Bolisetty, A. C. Dealmeida et al., "Hemeoxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase," Laboratory Investigation, vol. 93, no. 8, pp. 868-879, 2013.
21. P. Mandal, S. Roychowdhury, P.-H. Park, B. T. Pratt, T. Roger, and L. E. Nagy, "Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure," The Journal of Immunology, vol. 185, no. 8, pp. 4928-4937, 2010.
22. P. Mandal, M. T. Pritchard, and L. E. Nagy, "Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/ interleukin-10/heme oxygenase-1 pathway," World Journal of Gastroenterology, vol. 16, no. 11, pp. 1330-1336, 2010.
23. M. Packiam, H. Wu, S. J. Veit, N. Mavrogiorgos, A. E. Jerse, and R. R. Ingalls, "Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice," Mucosal Immunology, vol. 5, no. 1, pp. 19-29, 2012.
24. J. Mishra, C. Dent, R. Tarabishi et al., "Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery," The Lancet, vol. 365, no. 9466, pp. 1231-1238, 2005.
25. S. Chakraborty, S. Kaur, S. Guha, and S. K. Batra, "The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer," Biochimica et Biophysica Acta: Reviews on Cancer, vol. 1826, no. 1, pp. 129-169, 2012.
26. G. Bao, M. Clifton, T. M. Hoette et al., "Iron traffics in circulation bound to a siderocalin (Ngal) - catechol complex," Nature Chemical Biology, vol. 6, no. 8, pp. 602-609, 2010.
27. D. H. Goetz, M. A. Holmes, N. Borregaard, M. E. Bluhm, K. N. Raymond, and R. K. Strong, "The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition," Molecular Cell, vol. 10, no. 5, pp. 1033-1043, 2002.
28. T. H. Flo, K. D. Smith, S. Sato et al., "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron," Nature, vol. 432, no. 7019, pp. 917-921, 2004.
29. M. E. Peek, A. Bhatnagar, N. A. McCarty, and S. M. Zughaier, "Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition," Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 843509, 10 pages, 2012.
30. M. de Sousa, S. J. Oliveira, and J. P. Pinto, "ER stress and iron homeostasis: a new frontier for the UPR," Biochemistry Research International, vol. 2011, Article ID 896474, 10 pages, 2011.
31. J.-J. Yin, Y.-B. Li, Y. Wang et al., "The role of autophagy in endoplasmic reticulum stress-induced pancreatic β cell death," Autophagy, vol. 8, no. 2, pp. 158-164, 2012.
32. D. H. Suh, M.-K. Kim, H. S. Kim, H. H. Chung, and Y. S. Song, "Unfolded protein response to autophagy as a promising druggable target for anticancer therapy," Annals of the New York Academy of Sciences, vol. 1271, no. 1, pp. 20-32, 2012.
33. C. Vecchi, G. Montosi, K. Zhang et al., "ER stress controls iron metabolism through induction of hepcidin," Science, vol. 325, no. 5942, pp. 877-880, 2009.
34. S. J. Oliveira, J. P. Pinto, G. Picarote et al., "ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity," PLoS ONE, vol. 4, no. 8, Article ID e6618, 2009.
35. R. Vidal, B. Caballero, A. Couve, and C. Hetz, "Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease," Current Molecular Medicine, vol. 11, no. 1, pp. 1-12, 2011.
36. S. Matus, L. H. Glimcher, and C. Hetz, "Protein folding stress in neurodegenerative diseases: a glimpse into the ER," Current Opinion in Cell Biology, vol. 23, no. 2, pp. 239-252, 2011.
37. X. Qu, Z. Zou, Q. Sun et al., "Autophagy gene-dependent clearance of apoptotic cells during embryonic development," Cell, vol. 128, no. 5, pp. 931-946, 2007.
38. S. M. Zughaier, Y.-L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens, "Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway," Infection and Immunity, vol. 72, no. 1, pp. 371-380, 2004.
39. S. M. Zughaier, "Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2," Journal of Leukocyte Biology, vol. 89, no. 3, pp. 469-480, 2011.
40. O. Kakhlon and Z. I. Cabantchik, "The labile iron pool: characterization, measurement, and participation in cellular processes," Free Radical Biology & Medicine, vol. 33, no. 8, pp. 1037-1046, 2002.
41. D. Gerlier and N. Thomasset, "Use of MTT colorimetric assay to measure cell activation," Journal of Immunological Methods, vol. 94, no. 1-2, pp. 57-63, 1986.
42. T. Mosmann, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays," Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55-63, 1983.
43. Y. Nakayama, M. Endo, H. Tsukano, M. Mori, Y. Oike, and T. Gotoh, "Molecular mechanisms of the LPS-induced non-apoptotic ER stress-CHOP pathway," The Journal of Biochemistry, vol. 147, no. 4, pp. 471-483, 2010.
44. S. M. Zughaier, V. Tangpricha, T. Leong, A. A. Stecenko, and N. A. McCarty, "Peripheral monocytes derived from patients with cystic fibrosis and healthy donors secrete ngal in response to Pseudomonas aeruginosa infection," Journal of Investigative Medicine, vol. 61, no. 6, pp. 1018-1025, 2013.
45. N. R. Mahadevan, J. Rodvold, G. Almanza, A. F. Pérez, M. C. Wheeler, and M. Zanetti, "ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner," BMC Cancer, vol. 11, article 229, 2011.
46. S. Immenschuh, E. Baumgart-Vogt, and S. Mueller, "Heme oxygenase-1 and iron in liver inflammation: a complex alliance," Current Drug Targets, vol. 11, no. 12, pp. 1541-1550, 2010.
47. J. A. Alvarez, S. M. Zughaier, J. Law et al., "Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease," European Journal of Clinical Nutrition, vol. 67, no. 3, pp. 264-269, 2013.
48. R. E. Grossmann, S. M. Zughaier, S. Liu, R. H. Lyles, and V. Tangpricha, "Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation," European Journal of Clinical Nutrition, vol. 66, no. 9, pp. 1072-1074, 2012.
49. J. A. Alvarez, J. Law, K. E. Coakley et al., "High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebocontrolled trial," The American Journal of Clinical Nutrition, vol. 96, no. 3, pp. 672-679, 2012.
50. S. M. Zughaier, J. A. Alvarez, J. H. Sloan, R. J. Konrad, and V. Tangpricha, "The role of vitamin D in regulating the iron-hepcidin-ferroportin axis inmonocytes," Journal of Clinical and Translational Endocrinology, vol. 1, no. 1, pp. e19-e25, 2014.
51. 2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients," The Journal of Steroid Biochemistry and Molecular Biology, vol. 136, no. 1, pp. 309-312, 2013.
52. A. E. Riek, J. Oh, J. E. Sprague et al., "Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients," Journal of Biological Chemistry, vol. 287, no. 46, pp. 38482-38494, 2012.
53. C. G. Leon, R. Tory, J. Jia, O. Sivak, and K. M. Wasan, "Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases," Pharmaceutical Research, vol. 25, no. 8, pp. 1751-1761, 2008.
54. T. M. El-Achkar, M. Hosein, and P. C. Dagher, "Pathways of renal injury in systemic gram-negative sepsis," European Journal of Clinical Investigation, vol. 38, no. 2, pp. 39-44, 2008.
55. S. Deegan, S. Saveljeva, A. M. Gorman, and A. Samali, "Stress-induced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress," Cellular and Molecular Life Sciences, vol. 70, no. 14, pp. 2425-2441, 2013.
56. G. Cairo, S. Recalcati, A. Mantovani, and M. Locati, "Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype," Trends in Immunology, vol. 32, no. 6, pp. 241-247, 2011.
57. G. Corna, L. Campana, E. Pignatti et al., "Polarization dictates iron handling by inflammatory and alternatively activated macrophages," Haematologica, vol. 95, no. 11, pp. 1814-1822, 2010.
58. A. Sindrilaru, T. Peters, S. Wieschalka et al., "An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice," The Journal of Clinical Investigation, vol. 121, no. 3, pp. 985-997, 2011.
59. C. Peyssonnaux, A. S. Zinkernagel, V. Datta, X. Lauth, R. S. Johnson, and V. Nizet, "TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens," Blood, vol. 107, no. 9, pp. 3727-3732, 2006.
60. R. J. Abergel, M. C. Clifton, J. C. Pizarro et al., "The siderocalin/ enterobactin interaction: a link between mammalian immunity and bacterial iron transport," Journal of the American Chemical Society, vol. 130, no. 34, pp. 11524-11534, 2008.
61. P. Bahmani, R. Halabian, M. Rouhbakhsh et al., "Neutrophil gelatinase-associated lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2," Cell Stress and Chaperones, vol. 15, no. 4, pp. 395-403, 2010.
62. A. Yndestad, L. Landrø, T. Ueland et al., "Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure," European Heart Journal, vol. 30, no. 10, pp. 1229-1236, 2009.
63. H. Zhang, L. Xu, D. Xiao et al., "Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion," Journal of Clinical Pathology, vol. 60, no. 5, pp. 555-561, 2007.
64. S. M. Zughaier, V. Tangpricha, T. Leong, A. A. Stecenko, and N. A. McCarty, "Peripheral monocytes derived from patients with cystic fibrosis and healthy donors secrete ngal in response to Pseudomonas aeruginosa infection," Journal of Investigative Medicine, vol. 61, no. 6, pp. 1018-1025, 2013.
65. J. M. Warszawska, R. Gawish, O. Sharif et al., "Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes," Journal of Clinical Investigation, vol. 123, no. 8, pp. 3363-3372, 2013.
66. N. Kawasaki, R. Asada, A. Saito, S. Kanemoto, and K. Imaizumi, "Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue," Scientific Reports, vol. 2, article 799, 2012.
67. T. Gotoh, M. Endo, and Y. Oike, "Endoplasmic reticulum stress-related inflammation and cardiovascular diseases," International Journal of Inflammation, vol. 2011, Article ID 259462, 8 pages, 2011.
68. H. Zhang, S. Nakajima, H. Kato et al., "Selective, potent blockade of the IRE1 and ATF6 pathways by 4-phenylbutyric acid analogues," British Journal of Pharmacology, vol. 170, no. 4, pp. 822-834, 2013.
69. F.-D. Wang, D.-B. Zhou, S.-L. Li et al., "Effect of recombinant human erythropoietin on hepcidin mRNA expression in patients with multiple myeloma," Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 19, no. 2, pp. 390-394, 2011.
70. R. Pecoits-Filho, P. Bárány, B. Lindholm, O. Heimbürger, and P. Stenvinkel, "Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment," Nephrology Dialysis Transplantation, vol. 17, no. 9, pp. 1684-1688, 2002.
71. B. McDonald, S. Moyo, L. Gabaitiri et al., "Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial," AIDS Research and Human Retroviruses, vol. 29, no. 7, pp. 993-999, 2013.
72. R. P. Andríe, U. M. Becher, R. Frommold et al., "Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction," Critical Care, vol. 16, no. 4, article R152, 2012.
73. K. M. Erlandson, A. A. Allshouse, C. M. Jankowski et al., "Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy," The Journal of Infectious Diseases, vol. 208, no. 2, pp. 249-259, 2013.
74. J. Zhang, Y. Wu, Y. Zhang, D. Leroith, D. A. Bernlohr, and X. Chen, "The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages," Molecular Endocrinology, vol. 22, no. 6, pp. 1416-1426, 2008.
75. B. M. Dixon, T. Barker, T. McKinnon et al., "Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults," BMC Research Notes, vol. 5, article 575, 2012.
76. V. Wiwanitkit, "Quantum chemical analysis of the deferiproneiron binding reaction," International Journal of Nanomedicine, vol. 1, no. 1, pp. 111-113, 2006.
77. V. M. Nurchi, G. Crisponi, T. Pivetta, M. Donatoni, and M. Remelli, "Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone," Journal of Inorganic Biochemistry, vol. 102, no. 4, pp. 684-692, 2008.
78. G. J. Kontoghiorghes, A. Spyrou, and A. Kolnagou, "Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption," Hemoglobin, vol. 34, no. 3, pp. 251-264, 2010.
79. M. A. Fischbach, H. Lin, D. R. Liu, and C. T. Walsh, "How pathogenic bacteria evade mammalian sabotage in the battle for iron," Nature Chemical Biology, vol. 2, no. 3, pp. 132-138, 2006.
80. H. T. Chang, L. K. Olson, and K. A. Schwartz, "Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy," Nutrition and Metabolism, vol. 10, no. 1, article 47, 2013.